ANI PHARMACEUTICALS INC (ANIP) › Operating IncomeANI PHARMACEUTICALS INC (ANIP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$42.0K2013: $898.0K2014: $20.01M2015: $32.70M2016: $20.08M2017: $28.33M2018: $35.36M2019: $16.35M2020: -$16.02M2021: -$39.79M2022: -$35.28M2023: $46.97M2024: $584.0K2025: $111.09M$111.09M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$111.09M+18922.8%2024$584.0K-98.8%2023$46.97M+233.1%2022-$35.28M+11.3%2021-$39.79M-148.5%2020-$16.02M-198.0%2019$16.35M-53.8%2018$35.36M+24.8%2017$28.33M+41.1%2016$20.08M-38.6%2015$32.70M+63.5%2014$20.01M+2127.8%2013$898.0K+2238.1%2012-$42.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share